T1	Participants 143 184	adults with severe hemophilia A (SPINART)
T2	Participants 341 373	older patients with hemophilia A
T3	Participants 707 925	Males aged 12-50 years with severe hemophilia A, ≥ 150 days of exposure to FVIII, no FVIII inhibitors, no prophylaxis for > 12 consecutive months in the past 5 years and 6-24 bleeding episodes in the preceding 6 months
T4	Participants 1368 1415	Eighty-four patients were enrolled and analyzed
